English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/97338
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Citado 6 veces en Web of Knowledge®  |  Pub MebCentral Ver citas en PubMed Central  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar otros formatos: Exportar EndNote (RIS)Exportar EndNote (RIS)Exportar EndNote (RIS)
Título

Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma

Autor Castro-Sánchez, Luis; Agra, Noelia ; Llorente-Izquierdo, Cristina ; Motiño, Omar ; Casado, Marta ; Boscá, Lisardo ; Martín-Sanz, Paloma
Palabras clave COX-2
15-PGDH
HCC
Apoptosis
Tumor growth
Fecha de publicación 15-ago-2013
EditorElsevier
Citación International Journal of Biochemistry and Cell Biology 45(11): 2501-2511 (2013)
ResumenCyclooxygenase-2 (COX-2), a rate limiting step in arachidonic acid cascade, plays a key role in the biosynthesis of prostaglandin E2 (PGE2) upon inflammatory stimuli, growth factors, hormones and other cellular stresses. Overproduction of PGE2 stimulates proliferation of various cancer cells, confers resistance to apoptosis and favors metastasis and angiogenesis. The steady-state level of PGE2 is maintained by interplay between the biosynthetic pathway including COX and PGE2 synthases and the catabolic pathways involving nicotinamide adenine dinucleotide (NAD(+))-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH). 15-PGDH is a crucial enzyme responsible for the biological inactivation of PGE2. Adult hepatocytes fail to induce COX-2 expression regardless of the pro-inflammatory factors used. COX-2 is induced in hepatocytes after partial hepatectomy (PH), in animal models of cirrhosis, in human hepatoma cell lines, in human HCC and after HBV and HCV infection. However, no data are available regarding 15-PGDH expression in HCC. Our results show that 15-PGDH is downregulated in human hepatoma cells with a high COX-2 expression, in chemical and genetic murine models of HCC and in human HCC biopsies. Moreover, 15-PGDH expression is suppressed by EGF (epidermal growth factor) and HGF (hepatocyte growth factor) mainly involving PI3K (phosphatidylinositol-3-kinase), ERK (extracellular signal-regulated kinase) and p38MAPK (mitogen-activated protein kinase) activation. Conversely, ectopic expression of 15-PGDH induces apoptosis in hepatoma cells and decreases the growth of hepatoma cells in nude mice whereas the silencing of 15-PGDH increases the tumor formation. These data suggest a potential therapeutic application of 15-PGDH in HCC
Descripción 11 páginas, 6 figuras.
Versión del editorhttp://dx.doi.org/10.1016/j.biocel.2013.08.005
URI http://hdl.handle.net/10261/97338
DOI10.1016/j.biocel.2013.08.005
ISSN1357-2725
E-ISSN1878-5875
Aparece en las colecciones: (IBV) Artículos
(IIBM) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
2013 Int J Biochem Cell Biol 45-2501.pdf452,92 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.